The low priority accorded to health care in India has resulted in a vicious cycle of disease, death and destitution. Over 63 million Indians slip into poverty every year as high health care costs......
Biotechnology major Biocon has bagged the 2009 BioSingapore Asia Pacific Biotechnology Award for being the Best Listed Company. Biocon was selected on the basis of its significant market capital,......
Biocon Ltd ill seek Drug Controller General of India's approval for its novel monoclonal antibody indicated towards the treatment of head and neck cancer, Biomab EGFR."We will be submitting an......
India's largest biotechnology firm Biocon could be developing potential 'blockbuster' drugs for treatment of cancer and diabetes, but the company's CMD Kiran Mazumdar-Shaw said it could take......
Amid the global meltdown and downsizing of staff by several firms, leading biotechnology firm Biocon on Thursday said it plans to hire around 200 more people in this fiscal. "We will continue to......
Streamlining the regulatory mechanism for approval of biotech products and enhancing industry-academia research linkages will put India on a global biotechnology map, Kiran Mazumdar Shaw, CMD of......